Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Actualités Accéder au fil d'actualités
Nature’s Miracle enters partnership with FF AI-Robotics for robotics deployment in North America
Nature’s Miracle has signed a letter of intent with FF AI-Robotics to support the “Robotics Partnership Program” in North America. The partners plan to build a network of showrooms, operations and service centers; Nature’s Miracle will handle marketing, customer operations and infrastructure development, while FF will provide product training and operational support. Nature’s Miracle has already received deliveries of FF robots, and program participants are expected to be able to earn revenue over the robots’ lifecycle. The company is expanding its focus to robotics and AI infrastructure but faces significant financial problems, including low market capitalization, high debt and a sharply fallen share price. » Plus sur de.investing.com
Nature’s Miracle Holding: Q3‑2025 financial report no longer reliable due to omission of short‑term loans
Nature’s Miracle Holding said the previously issued unaudited consolidated financial statements and disclosures for the quarter ended September 30, 2025 are no longer reliable due to an omission related to short‑term loans. Management announced it will file an amended Form 10‑Q/A to properly account for the loan and has discussed the matter with its auditors and the audit committee. » Plus sur de.investing.com
Nature’s Miracle settles USD 6.9m debt by issuing shares to Megaphoton
Nature’s Miracle settles trade payables of USD 6.9 million to Megaphoton by issuing 15 million common shares at USD 0.46 per share (about 13% of share capital) and also reimburses USD 300,000 in legal costs. The transaction ends the lawsuit ongoing since 2022, results in a one‑time gain of USD 6.9 million and increases equity in Q1 2026. Despite the relief, the financial position remains strained: the stock trades around USD 0.05 and the liquidity ratio is only 0.12. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | mars 2026 | |
|---|---|---|
| Chiffre d'affaires | 35,94 k | 96,49 % |
| Bénéfice brut | -144,53 k | 189,19 % |
| Bénéfice net | 2,46 M | 231,64 % |
| EBITDA | -792,76 k | 11,31 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 17,68 k € |
Nombre d'actions | 20,48 M |
Plus haut/bas sur 52 semaines | 0,40 € - 0,000518 € |
| Dividendes | Non |
Bêta | 0,69 |
Ratio P/E | 0,00 |
Ratio PEG | 0,00 |
Ratio P/B | -0,02 |
Ratio P/S | 0,03 |
Profil de l'entreprise
| Nom | Nature's Miracle Aktie |
| PDG | Tie Li |
| Employés | 11 |
Découvrir des actifs
Les actionnaires de Nature's Miracle Aktie investissent également dans les actifs suivants


